XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Common Stock Common Stock        
As of March 31, 2023 and December 31, 2022, there were 47,635,583 and 47,666,725 shares of our common stock outstanding, respectively.
During the three months ended March 31, 2023 and 2022, we issued 72,076 and 95,331 shares of common stock, respectively. These shares were issued upon either the satisfaction of required conditions under our share-based compensation plans or the purchase of common stock pursuant to our employee stock purchase plan.
We have paid quarterly dividends since October 25, 2011. Commencing with the dividend to be paid on April 28, 2023, our dividend will increase from $0.15 per share to $0.18 per share.
NOTE 10 - Common Stock (Continued)
In September 2011, our Board of Directors (the “Board”) authorized a share repurchase program allowing us to begin repurchasing shares of our outstanding common stock. Subsequently, the Board has from time to time increased the amount authorized for repurchases under such program. Since the inception of the repurchase program, the Board has authorized us to repurchase up to $2.15 billion of our outstanding common stock. During the three months ended March 31, 2023, we repurchased approximately 0.1 million shares of our common stock for approximately $16.1 million. Since the inception of the repurchase program through March 31, 2023, we have repurchased approximately 25.1 million shares of our common stock for approximately $1.78 billion. As of March 31, 2023, there remained authorization for us to repurchase approximately $373.7 million of our shares. The repurchase program has no expiration date, does not obligate the Company to acquire any particular amount of common stock, and may be suspended, recommenced, or discontinued at any time or from time to time without prior notice. We may repurchase our shares from time to time to the extent permitted by securities laws and other legal requirements, including provisions in our 2020 Credit Agreement placing limitations on such repurchases.
The Inflation Reduction Act of 2022, which was enacted into law on August 16, 2022, imposes a nondeductible excise tax of 1% on the fair value of net stock repurchases in excess of share issuances made by publicly traded U.S. corporations, effective for repurchases after December 31, 2022. Starting with the first quarter of 2023, we have included the applicable excise tax as a component of treasury stock as it represents a direct cost associated with the repurchase of our common stock.